Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00176540 · ClinicalTrials.gov registry record · NA
Dextromethorphan in Treating Patients With Fatigue Caused by Cancer
A NA study, sponsored by University of Medicine and Dentistry of New Jersey.
- Terminated
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT00176540 is a NA study that was terminated before completion, run by University of Medicine and Dentistry of New Jersey. The registered enrollment target is 30 participants.
The verdict
NCT00176540, a NA study, was terminated before completion, sponsored by University of Medicine and Dentistry of New Jersey.
- TERMINATED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
RATIONALE: Dextromethorphan may help relieve fatigue in patients with cancer. PURPOSE: This clinical trial is studying how well dextromethorphan works in treating patients with fatigue caused by cancer.
Interventions
- DRUG dextromethorphan hydrobromide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2003-10 |
| Est. Completion | 2007-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00176540
The ClinicalTrials.gov registry entry for NCT00176540 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Medicine and Dentistry of New Jersey, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which dextromethorphan hydrobromide is the first listed.
NCT00176540 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00176540 about?
NCT00176540 is a clinical study titled "Dextromethorphan in Treating Patients With Fatigue Caused by Cancer". RATIONALE: Dextromethorphan may help relieve fatigue in patients with cancer. PURPOSE: This clinical trial is studying how well dextromethorphan works in treating patients with fatigue caused by cancer.
What is the current status of trial NCT00176540?
This trial is currently terminated. It is a NA study. The enrollment target is 30 participants. The study started on 2003-10. Estimated completion is 2007-08.
What interventions are being tested in trial NCT00176540?
The interventions under investigation include: dextromethorphan hydrobromide (DRUG).
Who is sponsoring clinical trial NCT00176540?
This trial is sponsored by University of Medicine and Dentistry of New Jersey, which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.